613 related articles for article (PubMed ID: 16481342)
1. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
2. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
[TBL] [Abstract][Full Text] [Related]
3. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
[TBL] [Abstract][Full Text] [Related]
4. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
[TBL] [Abstract][Full Text] [Related]
5. Glatiramer acetate: mechanisms of action in multiple sclerosis.
Schrempf W; Ziemssen T
Autoimmun Rev; 2007 Aug; 6(7):469-75. PubMed ID: 17643935
[TBL] [Abstract][Full Text] [Related]
6. The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Youssef S; Stüve O; Patarroyo JC; Ruiz PJ; Radosevich JL; Hur EM; Bravo M; Mitchell DJ; Sobel RA; Steinman L; Zamvil SS
Nature; 2002 Nov; 420(6911):78-84. PubMed ID: 12422218
[TBL] [Abstract][Full Text] [Related]
7. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis.
Jee Y; Piao WH; Liu R; Bai XF; Rhodes S; Rodebaugh R; Campagnolo DI; Shi FD; Vollmer TL
Clin Immunol; 2007 Oct; 125(1):34-42. PubMed ID: 17632037
[TBL] [Abstract][Full Text] [Related]
8. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
Bettelli E; Das MP; Howard ED; Weiner HL; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3299-306. PubMed ID: 9759845
[TBL] [Abstract][Full Text] [Related]
9. Exposure to T helper 2 cytokines in vivo before encounter with antigen selects for T helper subsets via alterations in antigen-presenting cell function.
Cua DJ; Coffman RL; Stohlman SA
J Immunol; 1996 Oct; 157(7):2830-6. PubMed ID: 8816386
[TBL] [Abstract][Full Text] [Related]
10. Secretion of brain-derived neurotrophic factor by glatiramer acetate-reactive T-helper cell lines: Implications for multiple sclerosis therapy.
Ziemssen T; Kümpfel T; Schneider H; Klinkert WE; Neuhaus O; Hohlfeld R
J Neurol Sci; 2005 Jun; 233(1-2):109-12. PubMed ID: 15869765
[TBL] [Abstract][Full Text] [Related]
11. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
Liblau R
J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
[TBL] [Abstract][Full Text] [Related]
12. Glatiramer acetate: mechanisms of action in multiple sclerosis.
Ziemssen T; Schrempf W
Int Rev Neurobiol; 2007; 79():537-70. PubMed ID: 17531858
[TBL] [Abstract][Full Text] [Related]
13. A critical role for IL-4 in regulating disease severity in experimental allergic encephalomyelitis as demonstrated in IL-4-deficient C57BL/6 mice and BALB/c mice.
Falcone M; Rajan AJ; Bloom BR; Brosnan CF
J Immunol; 1998 May; 160(10):4822-30. PubMed ID: 9590229
[TBL] [Abstract][Full Text] [Related]
14. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
15. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
16. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease.
Cua DJ; Hinton DR; Stohlman SA
J Immunol; 1995 Oct; 155(8):4052-9. PubMed ID: 7561116
[TBL] [Abstract][Full Text] [Related]
17. Estrogen inhibition of EAE involves effects on dendritic cell function.
Liu HY; Buenafe AC; Matejuk A; Ito A; Zamora A; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2002 Oct; 70(2):238-48. PubMed ID: 12271473
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
Samoilova EB; Horton JL; Chen Y
Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
[TBL] [Abstract][Full Text] [Related]
19. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
[TBL] [Abstract][Full Text] [Related]
20. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
